Category: Latest News
-
Altimmune Shares Slide 37% Despite Hitting Key MASH Trial Goals
Altimmune Inc. (NASDAQ:ALT) saw its stock tumble by 37% after releasing topline data from its Phase 2b IMPACT trial evaluating pemvidutide for the treatment of metabolic dysfunction-associated steatohepatitis (MASH). The biopharmaceutical company reported that the trial met its primary goal—up to 59.1% of patients achieved resolution of MASH without worsening fibrosis based on an intent-to-treat…
-
Pfizer Reports Breakthrough Phase 3 Results for Hemophilia Therapy
Pfizer Inc. (NYSE:PFE) announced encouraging results from its Phase 3 clinical trial of HYMPAVZI, a potential new treatment for patients with hemophilia A or B who develop inhibitors—a major complication that limits the effectiveness of standard therapies. The company stated that HYMPAVZI outperformed existing treatments, achieving a 93% reduction in annualized bleeding rates among trial…
-
Acuity Brands Jumps Nearly 8% After Crushing Q3 Estimates
Shares of Acuity Brands Inc. (NYSE:AYI) surged by almost 8% in Thursday’s pre-market session after the company posted fiscal third-quarter results that blew past Wall Street forecasts. The Atlanta-based firm, known for its lighting and smart building technology, reported adjusted earnings per share of $5.12, far above the $4.30 consensus estimate. Revenue also came in…
-
Dollar Drops Sharply as Trump Targets Fed Chair Powell; Euro and Pound Rally
The U.S. dollar tumbled to its lowest level in over two years on Thursday amid renewed political attacks from former President Donald Trump against Federal Reserve Chair Jerome Powell, intensifying concerns over the Fed’s autonomy. By 08:30 GMT, the U.S. Dollar Index, which tracks the greenback against six major currencies, had slipped 0.6% to 96.682—a…
-
Micron Beats Expectations with Strong Q3 Results and Upbeat Guidance Fueled by AI Memory Demand
Micron Technology (NASDAQ:MU) saw its shares gain slightly in premarket U.S. trading Thursday after reporting robust third-quarter fiscal results and issuing positive guidance for the current quarter, driven by sustained demand for memory chips used in artificial intelligence applications. The company revealed a nearly 50% increase in sales of its high-bandwidth memory (HBM) chips compared…
-
Jefferies Shares Dip After Mixed Q2 Results; Analysts Anticipate Volatility Ahead
Shares of Jefferies Financial Group Inc (NYSE:JEF) slipped 2.5% in after-hours trading following the announcement of mixed financial results for the second quarter of fiscal 2025. The investment bank posted net revenue of $1.63 billion, surpassing analyst estimates, but earnings per share came in slightly below expectations at $0.40 versus the forecasted $0.42. Net income…
-
Gold Steady as Dollar Weakens Amid Easing Geopolitical Strains
Gold prices held their ground early Thursday in Asian trading, buoyed by a softer U.S. dollar after fresh political tensions surfaced between former President Donald Trump and Federal Reserve Chair Jerome Powell. The metal’s stability was also supported by a reduction in geopolitical risks following a ceasefire agreement between Israel and Iran. Spot gold remained…
-
Markets Edge Higher as Trump Weighs Powell Replacement – What’s Moving Markets Today
U.S. stock futures nudged upward on Thursday, with the S&P 500 hovering just below its all-time high. Market sentiment remains cautious as President Donald Trump reportedly considers replacing Federal Reserve Chair Jerome Powell later this year amid frustrations over the Fed’s cautious policy stance. Elsewhere, Chinese EV giant BYD slips on reports of production cutbacks,…
-
U.S. Stocks Close Little Changed Following Two-Day Surge
Stocks initially extended the rally seen to start the week early in the session on Wednesday before giving back ground over the course of the trading day. The major averages pulled back off their early highs, eventually ending the day narrowly mixed. While the tech-heavy Nasdaq rose 61.02 points or 0.3 percent to a new…
-
Oracle Stock Climbs to Record High of $216.60, Backed by Cloud and AI Growth
Oracle Corporation (NYSE:ORCL) hit a new all-time peak with its stock price reaching $216.60, underscoring the company’s strong momentum in the technology sector. Valued at over $600 billion, Oracle’s shares have surged 56.4% in the past year, driven by its leadership in cloud computing and enterprise software solutions. The firm’s solid financial base is reflected…